002317 众生药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)6.308-7.2346.5348.9737.932
总资产报酬率 ROA (%)4.675-4.9814.3046.0325.737
投入资产回报率 ROIC (%)5.217-5.5594.7986.6566.283

边际利润分析
销售毛利率 (%)56.79556.03458.59664.85766.796
营业利润率 (%)15.287-11.34611.44313.98512.872
息税前利润/营业总收入 (%)14.959-13.25511.50915.90114.731
净利润/营业总收入 (%)12.998-15.1569.57311.78411.308

收益指标分析
经营活动净收益/利润总额(%)91.555-71.135111.06888.538105.659
价值变动净收益/利润总额(%)2.019-1.980-14.7027.290-14.883
营业外收支净额/利润总额(%)-0.48816.652-5.314-1.618-1.029

偿债能力分析
流动比率 (X)3.7322.8773.9012.9185.096
速动比率 (X)3.3122.5103.3882.4844.234
资产负债率 (%)20.15627.79129.92733.91727.822
带息债务/全部投入资本 (%)8.71614.22610.78117.49111.050
股东权益/带息债务 (%)995.137554.749696.408409.311698.178
股东权益/负债合计 (%)386.934253.650225.383189.029254.843
利息保障倍数 (X)-58.794-37.05117.9007.4367.400

营运能力分析
应收账款周转天数 (天)81.39773.95367.71866.89466.378
存货周转天数 (天)130.799159.599166.773178.616191.041